For the quarter ending 2026-03-31, BEN had $84.2M increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 346.6 | 346.8 | 188.5 | 348.7 |
| Stock-based compensation | 52.8 | 75.6 | 44.8 | 112.7 |
| Amortization of deferred sales commissions | 25.3 | 22.8 | 20.9 | 34.9 |
| Depreciation and other amortization | 29.4 | 28.8 | 31.1 | 62.5 |
| Amortization of intangible assets | 50.6 | 55.1 | 69.2 | 196.2 |
| Impairment of intangible assets | 0 | - | 202.2 | 0 |
| Net losses on investments | -20.7 | -8.6 | 4.1 | -55.7 |
| Income from investments in equity method investees | 24.3 | 11.5 | 39.5 | 64 |
| Net (gains) losses on investments of consolidated investment products | 38.8 | 67.4 | 67.2 | 16.3 |
| Net purchase of investments by consolidated investment products | 375.7 | 97.7 | 281.8 | 84.2 |
| Deferred income taxes | 29.2 | 63.1 | -8.9 | -18.4 |
| Other | -20.4 | -18.9 | 14.5 | -127.6 |
| Increase in receivables and other assets | 208.7 | 121.9 | 153 | -66.2 |
| Decrease (increase) in investments, net | -8.3 | 12.4 | -3.5 | -26 |
| Decrease in accrued compensation and benefits | 184.4 | -562.3 | 150.8 | 585.3 |
| Increase in income taxes payable | - | 20.3 | 62.8 | 71.4 |
| Decrease in accounts payable, accrued expenses and other liabilities | -124.5 | -24.8 | -218 | 263.4 |
| Decrease in accounts payable and accrued expenses of consolidated investment products | -3 | 2.9 | -7.5 | 42.8 |
| Net cash used in operating activities | -27.6 | -255.1 | -20.7 | 1,282.1 |
| Purchase of investments | 369 | 264.6 | 132.8 | 359.3 |
| Liquidation of investments | 237.9 | 218.7 | 332.3 | -36.3 |
| Purchase of investments by consolidated collateralized loan obligations | 2,239.2 | 1,705.6 | 1,658.3 | 1,681.2 |
| Liquidation of investments by consolidated collateralized loan obligations | 1,017.5 | 1,492.7 | 1,265.2 | 1,296.3 |
| Additions of property and equipment, net | - | - | 31.2 | 14 |
| Proceeds from sale of property, plant, and equipment | -4.8 | 9.3 | - | - |
| Acquisition, net of cash acquired | 0 | 69.7 | 0 | 0 |
| Payments of contingent consideration asset | - | - | 0 | - |
| Payments of deferred consideration liability | - | - | 0 | 90.5 |
| Net consolidation (deconsolidation) of investment products | -1.1 | 2 | -216.6 | 4.3 |
| Net cash used in investing activities | -1,358.7 | -317.2 | -441.4 | -880.7 |
| Issuance of common stock | 13 | - | 13.9 | 0 |
| Dividends paid on common stock | 176.4 | 170.2 | 171.1 | 173.2 |
| Repurchase of common stock | 57.1 | 41.9 | 67.1 | 157.4 |
| Proceeds from debt | 500 | - | 0 | 0 |
| Payment on debt | 600 | - | - | 0 |
| Proceeds from repurchase agreement | 0.5 | 0 | 46.7 | 56.8 |
| Payments on debt | - | - | 700 | - |
| Payments on repurchase agreement | -4.9 | -4.9 | -12.9 | -16.5 |
| Proceeds from debt of consolidated investment products | 2,060.5 | 2,540.8 | 845.7 | 1,917.5 |
| Payments on debt of consolidated investment products | 725.9 | 1,961.3 | 480.5 | 1,723.2 |
| Payments on contingent consideration liabilities | 0 | 0 | 0 | 6.1 |
| Noncontrolling interests | 481.4 | 124.9 | 213.8 | 85.7 |
| Net cash provided by financing activities | 1,491.1 | 487.4 | 88.5 | -16.4 |
| Effect of exchange rate on cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | -20.6 | -4.2 | -9.5 | 32.9 |
| Decrease in cash and cash equivalents | 84.2 | -89.1 | -383.1 | 417.9 |
| Cash and cash equivalents, beginning of period | 3,484.8 | 3,573.9 | 3,957 | 3,539.1 |
| Cash and cash equivalents, end of period | 3,569 | 3,484.8 | 3,573.9 | 3,957 |